Functional analysis of the Wilms' tumor suppressor gene WT1 in hematopoiesis.
Wilms 抑癌基因 WT1 在造血中的功能分析。
基本信息
- 批准号:08671216
- 负责人:
- 金额:$ 1.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Since the Wilms' tumor suppressor gene WTI is expressed in CD34-positive blood stem cells and leukemia, it is probable that WT1 is involved in leukemogenesis. To investigate if WT1 plays a role in leukemogenesis, we screend the WT1 gene from 20 cases of childhood acute myeloid leukemia for structural abnormality. SSCP analysis revealed band shifts suggesting the presence of mutations in three cases. Mutations were confirmed by direct sequencing. A His to Glin substitution at codon 397 was found in acute megakaryoblastic leukemia developed in a patient of the Down syndrome. A His to Leu substitution at codon 405 and an Arg to Gln at codon 394 were found in two cases of acute myeloid leukemia respectively. Thus WT1 mutations were found in 15% of acute myeloid leukemia. These mutations occurred in Zn finger domains, which are important for transcriptional regultion. All the cases carrying WT1 mutations exhibited a poor prognosis, one of which possessed the WT1 mutation at relapse but not at diagnosis. The chromosome translocation t (8 ; 21) was also found in a case with the WT1 mutation. These data strongly suggest that mutations in Zn finger domains of the WT1 gene are associated with the progression of acute myeloid leukemia.
由于Wilms肿瘤抑制基因WTI在cd34阳性造血干细胞和白血病中表达,因此WT1可能参与了白血病的发生。为了研究WT1是否在白血病发生中起作用,我们从20例儿童急性髓性白血病中筛选了WT1基因的结构异常。SSCP分析显示三个病例中存在突变的条带移位。突变通过直接测序证实。在唐氏综合征患者发生的急性巨核母细胞白血病中发现了密码子397处的His与Glin替换。在2例急性髓系白血病中分别发现了密码子405处的His与Leu的替换和密码子394处的Arg与Gln的替换。因此,在15%的急性髓性白血病中发现了WT1突变。这些突变发生在锌指结构域,这对转录调控很重要。所有携带WT1突变的病例预后均较差,其中1例复发时携带WT1突变,但诊断时未携带WT1突变。染色体易位t(8; 21)也见于WT1突变病例。这些数据有力地表明,WT1基因Zn指结构域的突变与急性髓系白血病的进展有关。
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hosoya, N.: "Frameshift mutations of the hMSH6 gene in human leukemia cell lines." Japanese Journal of Cancer Research. 89 (1). 33-39 (1998)
Hosoya, N.:“人类白血病细胞系中 hMSH6 基因的移码突变。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sugimoto, K.: "Decreased or altered expression of the FHIT gene in human leukemia" Stem Cells. 15-3. 223-228 (1997)
Sugimoto, K.:“人类白血病中 FHIT 基因的表达降低或改变”干细胞。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ueno H.: "The phosphatidylinositol 3'kinase pathway is required for the survival signal of leukocyte tyrosine kinase." Oncogene. 14. 3067-3072 (1997)
Ueno H.:“磷脂酰肌醇 3 激酶途径是白细胞酪氨酸激酶的生存信号所必需的。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sugimoto, K.: "Decreased or altered expression of the FHIT gene in human leukemias" Stem Cells. 15 (3). 223-228 (1997)
Sugimoto, K.:“人类白血病中 FHIT 基因的表达降低或改变”干细胞。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mitani, K.: "No concomitant occurrence of the N-ras and p53 gene mutations in myelodysplastic syndromes." Leukemia. 11. 863-865 (1997)
Mitani, K.:“骨髓增生异常综合征中 N-ras 和 p53 基因突变不会同时发生。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MIYAGAWA Kiyoshi其他文献
MIYAGAWA Kiyoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MIYAGAWA Kiyoshi', 18)}}的其他基金
Regulation of radiation sensitivity by a pathway linking DNA repair with cell-cycle control
通过连接 DNA 修复和细胞周期控制的途径调节辐射敏感性
- 批准号:
15H04902 - 财政年份:2015
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Reguratory mechanisms of radiation sensitivity by molecules expressed in epigenetics-dependent manners
以表观遗传学依赖方式表达的分子的辐射敏感性调节机制
- 批准号:
24390289 - 财政年份:2012
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Individualized Cancer Therapy Using Cancer Testis Antigens
使用癌症睾丸抗原的个体化癌症治疗
- 批准号:
22650233 - 财政年份:2010
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Mechanisms of Centrosome Aberrations Induced by DNA damage
DNA损伤引起中心体畸变的机制
- 批准号:
21310034 - 财政年份:2009
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mechanisms of the signal transduction machinery in response to spontaneous DNA damage in human cells
信号转导机制响应人体细胞自发 DNA 损伤的机制
- 批准号:
18310037 - 财政年份:2006
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Prediction of Radiation Sensitivity by Functional Analysis of Reeombinational Repair Genes in Human Cells
通过人体细胞重组修复基因的功能分析预测辐射敏感性
- 批准号:
15310039 - 财政年份:2003
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Defective homologous recombination repair and carcinogenesis
有缺陷的同源重组修复和致癌作用
- 批准号:
12213088 - 财政年份:2000
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Functional analysis of WT1 mutation in acute myeloid leukemia
急性髓系白血病WT1突变的功能分析
- 批准号:
10670951 - 财政年份:1998
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of receptors for human colony-stimulating factor (GM-CSF and IL-3)
人集落刺激因子(GM-CSF 和 IL-3)受体的表征
- 批准号:
01570675 - 财政年份:1989
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
In Vitro and In Vivo Function of Platelet-Derived Endothelial Cell Growth Factor
血小板源性内皮细胞生长因子的体外和体内功能
- 批准号:
01870033 - 财政年份:1989
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B).
相似海外基金
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Operating Grants
Innovation of the novel therapeutic strategies against p53 mutated acute myeloid leukemia.
p53突变急性髓系白血病新治疗策略的创新。
- 批准号:
23K07824 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Fast-kinetics approaches to define direct gene-regulatory functions of MYB in leukemia
快速动力学方法定义 MYB 在白血病中的直接基因调控功能
- 批准号:
10644259 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
TET2-mediated epitranscriptomic regulation in leukemia microenvironment
TET2介导的白血病微环境中的表观转录组调控
- 批准号:
10801348 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Targeting Menin in Acute Leukemia with Upregulated HOX Genes
通过上调 HOX 基因靶向急性白血病中的 Menin
- 批准号:
10655162 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Targeting PLK1 in RAS mutant chronic myelomonocytic leukemia
RAS 突变型慢性粒单核细胞白血病中的靶向 PLK1
- 批准号:
10656778 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Combinatorial targeting for the treatment of B-cell acute lymphoblastic leukemia
治疗 B 细胞急性淋巴细胞白血病的组合靶向
- 批准号:
10973162 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Setting a new research agenda in North American pediatric acute lymphoblastic leukemia
制定北美儿童急性淋巴细胞白血病的新研究议程
- 批准号:
486909 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Miscellaneous Programs
Development of Synergistic Drug Combinations to Overcome Venetoclax Resistance in Acute Myeloid Leukemia
开发协同药物组合来克服急性髓系白血病的维奈托克耐药性
- 批准号:
23K07816 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




